体外反搏(ECP)是一种非创伤性循环辅助装置,实践证明这种装置只能小幅度提高主动脉舒张压,不能或很少降低收缩压,使其临床应用受到一定限制。国内于1974年以后,进行了ECP装置的改进以及临床和动物实验研究以来,进展甚速,至今就其基础研究的 Extracorporeal counterpulsation (ECP) is a non-invasive circulatory assist device. Practice has proved that this device can only slightly increase the aortic diastolic pressure, can not or rarely reduce systolic blood pressure, its clinical application is subject to certain restrictions. Since 1974, China has progressed rapidly since the ECP device improvement and clinical and animal experimental studies have been conducted, and so far its basic research